Literature DB >> 16596242

18FDG PET in oncology: the best and the worst (Review).

Tarik Belhocine1, Karoline Spaepen, Michelle Dusart, Catherine Castaigne, Kristof Muylle, Pierre Bourgeois, Daniel Bourgeois, Lawrence Dierickx, Patrick Flamen.   

Abstract

The clinical added-value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG PET) in the management of oncology patients is increasingly documented. In the present review, we discuss both the benefits and the limitations of 18FDG PET in different cancers. Considering the literature data and our own experience, we also indicate the best clinical approach to optimize the use of metabolic imaging in oncology.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16596242

Source DB:  PubMed          Journal:  Int J Oncol        ISSN： 1019-6439            Impact factor:   5.650


  24 in total

1.  Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Ingo Janssen; Elise M Blanchet; Karen Adams; Clara C Chen; Corina M Millo; Peter Herscovitch; David Taieb; Electron Kebebew; Hendrik Lehnert; Antonio T Fojo; Karel Pacak
Journal:  Clin Cancer Res       Date:  2015-04-14       Impact factor: 12.531

2.  Possible role of PET/CT in infective endocarditis.

Authors:  Susanne Haase Vind; Søren Hess
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

3.  ¹⁸F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis.

Authors:  Rachele Bonfiglioli; Cristina Nanni; Joshua James Morigi; Maddalena Graziosi; Filippo Trapani; Michele Bartoletti; Fabio Tumietto; Valentina Ambrosini; Alice Ferretti; Domenico Rubello; Claudio Rapezzi; Pier Luigi Viale; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

4.  Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer.

Authors:  Jian Zhang; Chang-Jing Zuo; Ning-Yang Jia; Jian-Hua Wang; Sheng-Ping Hu; Zhong-Fei Yu; Yuan Zheng; An-Yu Zhang; Xiao-Yuan Feng
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

Review 5.  Comprehensive review of evaluation and management of cardiac paragangliomas.

Authors:  Sri Harsha Tella; Abhishek Jha; David Taïeb; Keith A Horvath; Karel Pacak
Journal:  Heart       Date:  2020-05-22       Impact factor: 5.994

6.  Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.

Authors:  D Cafagna; G Rubini; F Iuele; N Maggialetti; A Notaristefano; D Pinto; A Niccoli-Asabella; G Palmiotti; M Lasciarrea; A Maggialetti
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

7.  Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on 18F-FDOPA PET Imaging.

Authors:  Zahraa Abdul Sater; Abhishek Jha; Adel Mandl; Sheila K Mangelen; Jorge A Carrasquillo; Alexander Ling; Melissa K Gonzales; Osorio Lopes Abath Neto; Markku Miettinen; Karen T Adams; Pavel Nockel; Mustapha El Lakis; Karel Pacak
Journal:  Nucl Med Mol Imaging       Date:  2019-02-19

8.  Endoscopic ultrasound-guided fine-needle aspiration in patients with lymphadenopathy suspected of recurrent malignancy after curative treatment.

Authors:  Takuji Iwashita; Ichiro Yasuda; Shinpei Doi; Masanori Nakashima; Hisashi Tsurumi; Yoshinobu Hirose; Tsuyoshi Takami; Masamichi Enya; Tsuyoshi Mukai; Takaya Ohnishi; Keisuke Iwata; Eiichi Tomita; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

9.  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Bastiaan Havekes; Graeme Eisenhofer; Lucia Martiniova; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

10.  PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.

Authors:  Ingo Janssen; Clara C Chen; Corina M Millo; Alexander Ling; David Taieb; Frank I Lin; Karen T Adams; Katherine I Wolf; Peter Herscovitch; Antonio T Fojo; Inga Buchmann; Electron Kebebew; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-21       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.